Krystal Biotech Inc (KRYS)
164.84
+0.39
(+0.24%)
USD |
NASDAQ |
May 21, 10:37
Krystal Biotech Total Return Price: 164.84 for May 21, 2024
Total Return Price Chart
Historical Total Return Price Data
| Date | Value |
|---|---|
| May 20, 2024 | 164.45 |
| May 17, 2024 | 164.10 |
| May 16, 2024 | 163.78 |
| May 15, 2024 | 163.19 |
| May 14, 2024 | 159.47 |
| May 13, 2024 | 154.82 |
| May 10, 2024 | 154.76 |
| May 09, 2024 | 158.74 |
| May 08, 2024 | 157.68 |
| May 07, 2024 | 161.76 |
| May 06, 2024 | 156.94 |
| May 03, 2024 | 161.10 |
| May 02, 2024 | 160.23 |
| May 01, 2024 | 159.67 |
| April 30, 2024 | 153.12 |
| April 29, 2024 | 157.99 |
| April 26, 2024 | 156.88 |
| April 25, 2024 | 155.68 |
| April 24, 2024 | 159.05 |
| April 23, 2024 | 162.04 |
| April 22, 2024 | 157.25 |
| April 19, 2024 | 158.53 |
| April 18, 2024 | 163.97 |
| April 17, 2024 | 169.64 |
| April 16, 2024 | 170.09 |
| Date | Value |
|---|---|
| April 15, 2024 | 169.75 |
| April 12, 2024 | 173.62 |
| April 11, 2024 | 179.94 |
| April 10, 2024 | 175.70 |
| April 09, 2024 | 179.77 |
| April 08, 2024 | 180.42 |
| April 05, 2024 | 180.02 |
| April 04, 2024 | 178.48 |
| April 03, 2024 | 177.87 |
| April 02, 2024 | 176.91 |
| April 01, 2024 | 176.07 |
| March 28, 2024 | 177.93 |
| March 27, 2024 | 177.20 |
| March 26, 2024 | 174.17 |
| March 25, 2024 | 169.46 |
| March 22, 2024 | 167.29 |
| March 21, 2024 | 169.80 |
| March 20, 2024 | 171.33 |
| March 19, 2024 | 167.00 |
| March 18, 2024 | 168.53 |
| March 15, 2024 | 172.98 |
| March 14, 2024 | 171.84 |
| March 13, 2024 | 179.35 |
| March 12, 2024 | 178.95 |
| March 11, 2024 | 170.39 |
Total Return Price Definition
The total return price allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions.
Total Return Price Range, Past 5 Years
27.20
Minimum
Jun 14 2019
180.42
Maximum
Apr 08 2024
73.81
Average
66.02
Median
Total Return Price Benchmarks
| Axsome Therapeutics Inc | 77.65 |
| Catalyst Pharmaceuticals Inc | 16.65 |
| EyePoint Pharmaceuticals Inc | 12.06 |
| Madrigal Pharmaceuticals Inc | 230.77 |
| Viking Therapeutics Inc | 67.14 |